Evidence map›Paper›PMID 41253127›Full record

ArticleAmerican journal of speech-language pathology2026

Preliminary Psychometric Review of Neurologists' Speech Ratings on the Unified Parkinson's Disease Rating Scale.

Kimberly L Dahl, Magdalen A Balz, Kara M Smith, Cara E Stepp

Abstract read
In one paragraph

Article in American journal of speech-language pathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kimberly L DahlDepartment of Speech, Language, and Hearing Sciences, Boston University, MA.ORCID 0000-0002-0525-8989
Magdalen A BalzDepartment of Speech, Language, and Hearing Sciences, Boston University, MA.
Kara M SmithDepartment of Neurology, University of Massachusetts Chan Medical School, Boston.ORCID 0000-0003-2760-9812
Cara E SteppDepartment of Speech, Language, and Hearing Sciences, Boston University, MA.ORCID 0000-0002-8045-252X

Funding

Advanced Research Training in Communication Sciences and DisordersT32DC013017 · NIDCD · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI Cara E. Stepp · 2016 to 2026
$4.9M
Objective Measures for Clinical Assessment of Voice DisordersR01DC015570 · NIDCD · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI STEPP, CARA E. · 2016 to 2025
$4.8M
Comprehensive assessment of speech physiology and acoustics in Parkinson's disease progressionR01DC020867 · NIDCD · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI Daryush Dinyar Mehta, Cara E. Stepp · 2023 to 2026
$2.8M
Speech markers of cognitive impairment in Parkinson's diseaseK23DC016656 · NIDCD · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SMITH, KARA MICHELLE · 2019 to 2023
$946k
Articulatory and prosodic sensorimotor adaptation in speaker-listener interactionsF31DC021080 · NIDCD · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI DAHL, KIMBERLY · 2023 to 2025
$114k
NIDCD NIH HHS F31 DC021080NIDCD NIH HHS K23 DC016656NIDCD NIH HHS R01 DC015570NIDCD NIH HHS R01 DC020867NIDCD NIH HHS T32 DC013017
6 · The paper itself

Abstract

purposeThe purpose of this study was to conduct a preliminary psychometric evaluation of the speech item of the Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS) Part III.

methodTwenty neurologists specializing in movement disorders evaluated the speech-unscripted and sentence reading-of people with Parkinson's disease (PD) on the MDS-UPDRS Part III. The concurrent validity of the speech item was evaluated by comparing the ratings to a previously collected estimate of the speakers' intelligibility during sentence reading. The reproducibility of the ratings was evaluated in terms of reliability (intra- and interrater) and agreement.

resultsMDS-UPDRS Part III speech ratings based on sentence reading were moderately and negatively correlated with previously collected estimates of intelligibility. No such relationship was found for MDS-UPDRS Part III speech ratings based on unscripted speech. Individual correlations for each rater ranged widely, with some showing weak, negligible, or positive relationships with intelligibility. Intrarater reliability was high, but interrater reliability was fair for both speech tasks. Movement disorders specialists agreed on MDS-UPDRS speech ratings, on average, less than 70% of the time.

conclusionsA critical communication outcome-intelligibility during unscripted speech-is not captured by MDS-UPDRS Part III speech ratings, suggesting weak concurrent validity of this widely used metric of speech function. The reproducibility of MDS-UPDRS Part III speech ratings across providers is fair. These speech ratings may be insufficient to assess the speech function of people with PD and identify those in need of speech services.

Indexed as

DysarthriaNeurologistsParkinson DiseaseSpeech DisordersSpeech IntelligibilitySpeech Production MeasurementAgedFemaleHumansMaleMiddle AgedObserver VariationPsychometricsReproducibility of ResultsSeverity of Illness IndexSpeech-Language Pathology

Identifiers

PMID41253127
PMCPMC12805817

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.